The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
von Willebrand factor binding to platelet GpIb initiates signals for platelet activation.
Open accessAbstract
The hypothesis that von Willebrand factor (vWF) binding to platelet membrane glycoprotein Ib (GpIb) initiates intracellular pathways of platelet activation was studied. We measured the biochemical responses of intact human platelets treated with ristocetin plus vWF multimers purified from human cryoprecipitate. vWF plus ristocetin causes the breakdown of phosphatidylinositol 4,5-bisphosphate, the production of phosphatidic acid (PA), the activation of protein kinase C (PKC), increase of ionized cytoplasmic calcium ([Ca2+]i), and the synthesis of thromboxane A2. PA production, PKC activation, and the rise of [Ca2+]i stimulated by the ristocetin-induced binding of vWF multimers to platelets are inhibited by an anti-GpIb monoclonal antibody, but are unaffected by anti-GpIIb-IIIa monoclonal antibodies. Indomethacin also inhibits these responses without impairing platelet aggregation induced by vWF plus ristocetin. These results indicate that vWF binding to platelets initiates specific intraplatelet signaling pathways. The mechanism by which this occurs involves an arachidonic acid metabolite-dependent activation of phospholipase C after vWF binding to platelet membrane GpIb. This signal then causes PKC activation and increases of [Ca2+]i, which promote platelet secretion and potentiate aggregation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
A new generation of Ca2+ indicators with greatly improved fluorescence properties.
Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,607
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Moake, J. L., Rudy, C. K., Troll, J. H., Weinstein, M. J., Colannino, N. M., Azocar, J., Seder, R. H., Hong, S. L., & Deykin, D. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212023072306 · Cited by 1,105
Self-citationColler, B. S., Peerschke, E. I., Scudder, L. E., & Sullivan, C. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110973 · Cited by 746
Moake, J. L., Turner, N. A., Stathopoulos, N. A., Nolasco, L. H., & Hellums, J. D. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112736 · Cited by 599
Self-citationColler, B. S. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111931 · Cited by 576
Coller, B., Peerschke, E., Scudder, L., & Sullivan, C. (1983) · Blood · doi:10.1182/blood.v61.1.99.99 · Cited by 460
Biochemical mechanisms of platelet activation
Kroll, M., & Schafer, A. (1989) · Blood · doi:10.1182/blood.v74.4.1181.1181 · Cited by 408
Self-citationPlatelet Membrane Glycoproteins
(1985) · Springer eBooks · doi:10.1007/978-1-4684-4880-1 · Cited by 178
Hemostatic properties of normal and perturbed vascular cells
Rodgers, G. M. (1988) · The FASEB Journal · doi:10.1096/fasebj.2.2.3277885 · Cited by 177
Sweatt, J. D., Blair, I. A., Cragoe, E. J., & Limbird, L. E. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)84431-9 · Cited by 158
Marco, L. D., Girolami, A., Russell, S., & Ruggeri, Z. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111816 · Cited by 146
Platelet activation by CD9 monoclonal antibodies is mediated by the FCγII receptor
Worthington, R. E., Carroll, R. C., & Boucheix, C. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb02568.x · Cited by 135
The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies.
Jennings, L., Fox, C. F., Kouns, W. C., McKay, C. P., Ballou, L. R., & Schultz, H. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39667-x · Cited by 128
Second messenger function of phosphatidic acid in platelet activation
Kroll, M. H., Zavoico, G. B., & Schafer, A. I. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041390315 · Cited by 84
Self-citationYamamoto, N., Greco, N., Barnard, M. R., Tanoue, K., Yamazaki, H., Jamieson, G., & Michelson, A. D. (1991) · Blood · doi:10.1182/blood.v77.8.1740.1740 · Cited by 72
Platelet Membrane Glycoproteins
Tomášková, J. (2000) · Chemické listy · Cited by 5
Cited by
Xu, S., Ilyas, I., Little, P. J., Li, H., Kamato, D., Zheng, X., Luo, S., Li, Z., Liu, P., Han, J., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000096 · Cited by 1,142
Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine
Lefkovits, J., Plow, E. F., & Topol, E. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506083322306 · Cited by 754
López, J. A., Andrews, R. K., Afshar-Kharghan, V., & Berndt, M. C. (1998) · Blood · doi:10.1182/blood.v91.12.4397 · Cited by 560
Malehmir, M., Pfister, D., Gallage, S., Szydlowska, M., Inverso, D., Kotsiliti, E., Leone, V., Peiseler, M., Surewaard, B. G. J., Rath, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0379-5 · Cited by 398
Bach, F. H., Winkler, H., Ferran, C., Hancock, W. W., & Robson, S. C. (1996) · Immunology Today · doi:10.1016/0167-5699(96)10024-4 · Cited by 388
Metadata
- Authors
- Kroll, M. H., Harris, T. S., Moake, J. L., Handin, R. I., & Schafer, A. I.
- Venue
- Journal of Clinical Investigation
- Published
- 1991-11-01
- Volume
- 88
- Issue
- 5
- Pages
- 1568-1573
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2016566683
- Cited by
- 266
- References
- 19
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.